Research graph
References from ASO Visual Abstract: Immune-Adjusted Nodal Risk Classification After Neoadjuvant Immunotherapy for Resectable Head and Neck Cutaneous Squamous Cell Carcinoma. Local targets link to admitted publications; unresolved targets remain external evidence.